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Probiotic Bacteria in Microbiome 
against Allergy
Najaf Allahyari Fard, Zakie Mazhary and Nahid Javanshir
Abstract
According to the World Allergy Organization (WAO), approximately 20% of the 
global population suffers from allergies. As per ongoing investigations, their per-
vasiveness is expanding comprehensively. Allergic diseases are significant because 
of the high prevalence and constant increase in their costs and adverse effects on 
human life. Probiotics are proposed as an intervention for the prevention and treat-
ment of allergic diseases. Various mechanisms are considered for the anti-allergic 
effects of probiotic properties, like detecting related molecular patterns, including 
DNA motifs or lipopolysaccharides (LPS) of the bacteria, through interaction 
with host immune systems by Toll-like receptors. In this chapter, the microbiome, 
allergy, and the role of immunomodulatory probiotics against allergy are discussed.
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1. Introduction
In industrialized countries, more than 20% of the population has symptoms 
of allergies. The commonness of childhood asthma increased by 50% in the USA 
from 1980 to 2000. The allergy mechanism is an immune response to the allergen, 
which is often mediated by the immunoglobulin E (IgE) antibody [1]. Allergies can 
be a serious risk for individuals. Allergens or pollens represent a small fraction of 
the proteins that humans are regularly exposed to. The importance of the topic in 
the uncertainty is the cause of the B and T cells’ responses to these proteins [2, 3]. 
Notably, some proteins that are structurally similar pollens may lead to immune 
response, known as cross-reactivity [4].
The human body microbiome has a diverse composition of bacteria, archaea, 
fungi, protozoa, and viruses, which are inhabited mainly in the different epidermal 
surfaces of the body—the skin and mucosal surface. Some of the species of these 
microbiotas are identified based on cultural techniques, but due to limitations of 
these techniques [5], it is suggested that the number of human microbiota exceeds 
1000 species or 10 times the number of cells in the entire body with 30 times larger 
total genome than the human genome.
A majority of these microbiotas are in the gastrointestinal tract, the major source 
of microbial exposure, and live in symbiosis with their host cells [6, 7]. Given up genes 
necessary for the survival of the commensal microbiota in other microenvironments 
and retained genes beneficial for the host with no or little benefit to themselves [8] are 
the evidences of the symbiotic coevolution of the microbiota and human [9].
The interplay of the immune system with gut microbiota starts from the day of 
birth and even before that. Early exposure during plasticity and prenatal period 
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seems to be beneficial to prevent the T helper cell type-2 (Th2)-mediated allergic 
disease [10]. Th2 phenotype is the dominant one in newborns [11] to prevent 
rejection in utero. Skewing to Th2 in the immune system leads to the stimulated 
secretion of IgE by B cells and hence to allergies as seen in germ-free mice with the 
same condition that results in greater IgE responses to food antigens and failure in 
producing the proper amount of regulatory T cell (Treg) responses [12–14]. On the 
other hand, upsurge in the amount of T helper cell type-1 (Th1) also mediates the 
autoimmune disease [12, 15–19].
Restoring Th1/Th2 is the significant role of the microbiota [20]. The associa-
tion of microbiota and the immune system is mutual. This engagement results in 
different signaling pathways through the immune system’s molecules that increase 
immune responses [21]. These regulations are crucial for maintaining the homeo-
stasis of the host and for the prevention of different diseases by inducing secretion 
of IgA and regulatory T cell (Treg) and stimulation of tolerance in face of common 
antigens [22]. So the formation, maintenance, and heterogeneity of microbiota are 
necessary during early life owing to their regulatory and tolerance properties in the 
immune system [23, 24], as it was confirmed that the lack of microflora during a 
short time in early life results in defection in immune regulation [15]. The mecha-
nisms of oral tolerance which are necessary to suppress excessive immune reactions 
to antigens are mediated by Foxp3þ Treg [25] and IgA, which is known as the most 
abundant immunoglobulin and is vital in establishing the composition of micro-
biota [26] and strengthening the mucosal barrier function [27].
Although, it is observed that abnormal IgA responses lead to allergy devel-
opment [28]. So the obligation of equilibrium of the allergy mediators is more 
sensible now.
Lack of genetic elements such as Toll-like receptors that cause enterocyte 
proliferation like TLR4 and CD14, which enhance the detection of bacterial LPS by 
TLR4, and TLR9, which identify the genetic molecules of the microorganisms, also 
increase susceptibility to allergies [29, 30].
As the priority of the microbiome is proven, some factors are mentioned as 
follows, to support their presence and diversity in the body. Mode of birth; surgi-
cal or natural delivery, the process of contacting microflora in the first moment of 
the presence. Breast or formula feeding; the extension of contact with microflora. 
Nutritional patterns; the habit of food, based on people’s patterns to eat fatty and 
fast foods or healthy ones like prebiotics which are considered beneficial for even the 
microbiota of the host. Antibiotics; the matter of using antibiotics at an early age or 
the trouble of overuse of them in all ages which impair normal flora. Locality; living 
in urban areas with all of the stresses, less interaction with nature in contrast with 
living in rural areas results in losing ancient commensal microbiota. Environmental 
factors; contacting people or animals. Hygiene; the obsession behaviors or normal 
ones. Lifestyle; the matter of activity or sedentariness in someone’s lifestyle.
Natural delivery and breastfeeding are the first two initial and essential expo-
sures when the immune system is not still mature and needs antigens to active oral 
tolerance [18, 25, 31]. Contravention of these simple factors grounds reformed 
patterns of early settlement which may result in the incidence of allergy [32]. Food 
sensitization especially milk allergy and atopic eczema are examples of reduced gut 
microbial diversity [33–37].
2. The function of the intestinal microbiota
The microbiome is considered as an active organ because of manufacturing 
intrinsic signals for shifting postnatal development, inspiration of tolerance 
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mechanisms and immunogenicity reduction, and resistance against invasive 
pathogens [38–42].
Consuming substrates of the microbiota containing fibers and mucins provides 
additional energy for the host as fatty acids [43]. Amines, sulfides, and ammonia 
are the products of them, which are detrimental metabolites for the human.
The protective barrier function against the invasive microbes by their coloniza-
tion in the intestine is another potential of the microbiota. Different mechanisms 
for the resistance colonization of the microbiota are considered, such as competition 
for nutrients and connection to the binding sites and secretion of the antimicrobial 
substances [44].
Stimulation of the innate signaling pathways through the straight cell-to-cell 
communications or secretion of short-chain fatty acids (SCFA) are the other 
regulatory actions of the microbiota. SCFAs produced by the microbiota can direct 
intestinal Treg cells and inhibit pro-inflammatory responses [45–48].
3. The intestinal microbiota of allergic ones
The role of maternal microbiota in the process of preventing allergy has been 
proven. Infants from allergic parents are at least twice more likely to the risk of 
developing allergic diseases than nonallergic parents. Microbiota diversity exists 
between allergic and nonallergic persons. Reduction in the fecal diversity of the 
bacteroidetes in pregnancy is connected with the prevalence of atopic eczema 
in their young children [49]. The microbiota of healthy infants with nonallergic 
parents frequently consists of healthy lactobacilli, representing the role of maternal 
microbiota in preventing allergic disorders. A decrease in the number of lactobacilli 
and bifidobacteria and an increase in the colonization of Staphylococcus aureus and 
Clostridium difficile are associated with the development of allergic disorders later 
in life, which shows the abnormality even before the onset of the allergy [50, 51]. 
Apart from quantitative alterations, qualitative alterations are important in the 
microbiota. For example, the microbiota of infants suffering from atopic dermatitis 
(AD) consists of mostly B. adolescentis which is mainly forming adult microbiota, 
whereas B. bifidum is the fundamental former of the healthy breastfeeding infants 
[52, 53]. Bifidobacteria of atopic dermatitis infants encourage the secretion of pro-
inflammatory cytokines, whereas the bifidobacterium of healthy ones encourages 
the secretion of anti-inflammatory cytokines [54]. Besides, these bifidobacteria 
have different adhesion behaviors to Caco-2 tissue culture cells [55] and intestinal 
mucus [56], which seems to be the reason for the reduction in stimulating the 
immune system. And at last, the metabolic activity of the microbiota composition 
is different too. Higher levels of butyrate, isovalerate, and caproate in the fecal 
matter of children with high risk for developing allergy in comparison with normal 
children are the confirmation of this claim [57].
4. Stabilizing intestinal bacterial flora
The intestine, the largest immune organ of the body, which is the source of the 
most antibody-producing cells [58] is the target of triggering maturation of the 
immune system or the restoration of the impaired commensal bacteria. Stimulation 
of the immune system is one of the most impressive functions of the resident 
microbiota of the intestine. Probiotic bacteria are considered as a safe solution 
for modulation of diminished commensal composition and also as influencer of 
the immune system in preventing allergic disorders [59]. Lactic acid bacteria and 
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bifidobacteria are good candidates as probiotics with an appropriate life span, no 
toxic or pathogenic properties, and no inflammatory induction. The selection of the 
bacteria as probiotics is mainly based on no harmful side effects during the history 
of their use for a long time. Consumption of these probiotics aid in balancing the 
ratio of the intestinal flora, avoiding the inhabiting of the pathogens by preventing 
the binding of them to the host cells, and suppressing the inflammation, which all 
are as the result of immune system regulation [60]. The effects of probiotics vary 
with the dose, strain, and duration of consumption and timing.
But the problem of the probiotics is their longevity and residence in the body of 
the host, as it was seen that they only remain during the administration period and 
not after that, showing the transient colonization of the probiotics [61–65].
Long-term effects of probiotics in different periods of everyone’s life need to be 
more investigated in complementary studies.
As it was mentioned, immune tolerance is one of the necessary immune reac-
tions to stop excessive inflammatory reactions. Preservation of this tolerance 
involves the integrity of the epithelial barrier that is heightened by commensal 
anaerobes, such as Clostridium spp. [15, 16, 66, 67], Bacteroides fragilis [68], and 
Clostridium spp. [66, 67], which are potent inducers, persuading Foxp3þ Treg dif-
ferentiation to maintain mucosal tolerance and intestine integrity. Clostridia class 
also has adaptation properties in the intestinal cells to the routine exposure of an 
extended range of the antigens. This adaptation is acquired by the effect of IL-22 
secreted by innate lymphoid cells which control enterocyte proliferation, activating 
the secretion of the mucus and antimicrobial production [16, 69].
5. Probiotics’ mechanisms of action in allergic disorders
Immune homeostasis develops in the gut as a relationship between the intestinal 
microbiota, the luminal antigens, and the epithelial barrier is established. Microbial 
intestinal colonization starts after conception. This happens when the newborn’s 
sterile gut is slowly colonized by environmental bacteria and by interaction with the 
mother’s intestinal flora and surroundings and probably by genetic factors [70–72]. 
Exposure to microbial flora early in life causes a transition in the T helper cell type-1 
(Th1)/Th2 cytokine balance, promoting a Th1 cell response [73].
An infant’s immune system at birth is not completely formed and appears to be 
geared toward a Th2 phenotype to prevent in utero rejection [74]. Nevertheless, the 
Th2 phenotype results in a stimulated production of IgE by B cells and therefore 
raises the risk of allergic reactions by mast cells activation [75, 76]. Early in life 
microbial stimulation will reverse the Th2 bias and promote the expansion of the 
Th1 phenotype and promote Th3 cell activity [76]. In this way, their combined 
activity will lead to B-cells releasing IgA. IgA contributes to the elimination of 
allergens and hence would reduce the immune system’s response to antigens. Th1 
phenotype-produced cytokines will also reduce inflammation and promote toler-
ance toward specific antigens [77].
The hygiene concept states that inadequate or aberrant exposure to environmental 
microbes is one of the triggers of allergy production and related diseases [78]. As men-
tioned before, allergic diseases are associated with a change in the Th1/Th2 cytokine 
balance leading to Th2 cytokine activation and interleukin-4 (IL-4), IL-5, and IL-13 
activation as well as IgE production [79, 80]. Probiotics significantly alter the gut 
microenvironment by encouraging a shift in local microflora and cytokine secretion 
[81] and can potentially modulate enterocyte Toll-like receptors and proteoglycan 
recognition proteins, resulting in dendritic cell (DC) activation and a Th1 response. 
The resulting stimulation of Th1 cytokines can suppress reactions to Th2 [82].
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6. Probiotics in atopic dermatitis
Atopic dermatitis (AD) is a widespread chronic inflammatory skin condition 
with a prevalence of around 20% in children and 2–5% in adults worldwide [83]. 
In recent years, the function of the intestinal microbiota in the aetiopathogenesis 
of AD has become increasingly important. Atopic dermatitis probiotic therapy 
is widely studied, with contradictory outcomes [84]. Probiotics containing 
Lactobacillus spp. for the treatment of infantile atopic dermatitis showed beneficial 
effects in children. Caution should however be raised when treating children under 
the age of 1 years of age [85]. In addition, mild subjects are exceptions to that 
beneficial effect. More studies could be informative in investigating the efficacy of 
Bifidobacterium strains. Further larger studies in the treatment of pediatric AD are 
also required to examine the health, dose-response profile, and long-term impact of 
probiotics [86].
7. Probiotics in asthma
Asthma, a chronic complex airway disease, is characterized by reversible airflow 
obstruction, bronchial hyper responsiveness, and underlying inflammation [87]. In 
recent decades, the prevalence of asthma has risen. One possible mechanism behind 
this high prevalence is the microbial hypothesis, which suggests that less microbial 
exposure upregulates T helper cell type-2 (Th2) cytokine development, leading to a 
rise in allergic diseases [75]. A meta-analysis found that while perinatal and early-life 
probiotic administration reduces children’s risk of atopic sensitization and total rates 
of immunoglobulin E (IgE), it may not reduce their risk of asthma [88]. However, 
in addition to routine treatment, several studies have documented the advantage 
of using probiotics for treating children with asthma. A randomized, placebo-
controlled trial for 7-week treatment with Enterococcus faecalis showed reduced peak 
flow variability in children with asthma [89]. Lee et al. have reported substantial 
improvements in the pulmonary function of children with asthma following a 
regimen of supplementation of vegetables, fish oil, and fruit along with probiotic 
administration. Studies, however, have shown that Lactobacillus is safe for children 
with asthma [90, 91].
8. Probiotics in allergic rhinitis
On these bases, probiotic bacteria are capable of altering immune responses 
through a range of mechanisms that could minimize allergic reactions to airborne 
allergens without the side effects of any current drugs, and these possible mecha-
nisms, as shown in Figure 1, include regulatory T cells that dampen immune 
responses and suppress the production of IgE antibodies [92, 93]. There are contra-
dictory studies about the effectiveness of probiotics in treating allergic rhinitis [94]. 
It is reported that L. casei decreased the number of episodes of rhinitis in 64 pre-
schoolers with allergic rhinitis [95]. Nonetheless, another study found that patients 
treated with Lactobacillus GG during the birch pollen season who were allergic 
to birch pollen and apple food found no improvement in symptom score and no 
reduced sensitivity to birch pollen and apple following probiotic supplementation 
[96]. Probiotic consumption increased life performance in allergic rhinitis patients. 
Blood or immunological parameters did not alter significantly in the probiotic 
community. This indicates probiotics may be useful in allergic rhinitis, but the data 
present are not sufficient to make any guidelines for treatment [97, 98].
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9. Probiotics in food allergy
Food allergy (FA) is one of the pediatric age’s most common allergic disorders 
and has been considered a global health issue, particularly in the developed 
world.
Naturally, many subjects with FA outgrow this over time. Cow’s milk allergy 
(CMA), hen’s egg allergy, and wheat allergy resolve by 5–10 years in 50% of chil-
dren. Many FAs (including peanuts, tree nuts, and fish) have low-resolution levels 
and are seen as persistent [99]. Furthermore, certain types of FA may be correlated 
with the subsequent development of other allergic symptoms such as oculorhinitis, 
atopic dermatitis, asthma, and urticaria (the so-called “Atopic March”) [100] as 
well as other diseases such as functional gastrointestinal disorders (FGIDs), inflam-
matory intestinal diseases (IBD) [101], and psychiatric disorders such as attentive 
autistic spectrum disorders (ASD).
The gut microbiome-immune system axis that influences the frequency of FA 
may be modulated by several genetic, environmental, and dietary factors [102]. 
For example, increased family size, pet and/or rural exposure, balanced diet (full 
of fibers, fermented foods, antioxidants, omega-3), breastfeeding, and probiotic 
use are correlated with FA safety. Conversely, C-section, prenatal, and early-life 
exposure to antibiotics/gastric acid inhibitors/antiseptic agents, unhealthy diet (low 
fibers/high saturated fats, and junk foods) may increase the risk of developing FA. 
All these environmental factors mainly operate on a modulation of the structure 
and function of the gut microbiota, which may in effect be responsible for the 
epigenetic control of genes involved in immune tolerance.
The pathogenesis of these incidents also is largely unknown, but increasing 
evidence suggests the hypothesis that disturbance of intestinal microbiome, leading 
to alterations in the immune system and gut-brain axis, may affect the occurrence 
of FA and FA-related conditions later in life [103] (Figure 2).
Figure 1. 
Probiotic mechanism against the allergen include increasing regulatory T cells that damp down immune 
responses and suppress the production of IgE.
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Mediterranean diet (MD) is described as a healthy, balanced diet. It is associ-
ated with a high intake of assorted cereals, legumes, fruit, vegetables, olive oil, and 
nuts; moderate consumption of red wine, poultry, and fish; and a lower intake of 
red meat and sweets. MD has been shown to have a protective role against allergic 
illnesses in children during pregnancy and early life [104].
Elevated adherence to MD was associated with increased levels of Prevotella 
and other Firmicutes and production of short-chain fatty acids (SCFAs) [102]. One 
of the strongest links between diet, gut microbiome, and allergic diseases is the 
immunomodulatory mechanisms elicited by SCFAs [105]. Common SCFAs contain 
acetate, butyrate, propionate, and valerate. SCFA-producing bacteria include 
Faecalibacterium prausnitzii and Eubacterium rectale. Roseburia is an important 
butyrate producer [106]. SCFAs are a major source of energy for colonocytes and 
epigenetically influence many nonimmune functions (tightened junction proteins, 
and mucus production) and immune functions (macrophages, neutrophils, den-
dritic cells (DCs), and T and B cells) [107, 108]. Enterocyte interaction of SCFAs 
is mediated by G-protein-coupled receptors, namely GPCRs, GPR41, GPR43, 
GPR109A, and Olfr78 [109, 110]. The hopeful target of novel therapeutic and pre-
ventive approaches against FA may be the gut microbiome. The results of the studies 
are promising, but more research is needed for the better definition of the potential 
for diet-gut microbiome—immune system axis modulation to counter FA. We are 
entering a new age in which the production and function of the immune system can 
be controlled by dietary intervention, and the clinical effect can be assessed by gut 
microbes and their metabolites. Given the current gaps in research methods and 
data analysis and interpretation, more scientific evidence is required which can be 
converted into clinical evidence praxis [103].
10. Conclusion
The results of many studies have demonstrated that there is a strong relationship 
between modifications within the microbiome and many diseases. Much evidence 
proves that healthy microbiota affects and improves the immune system. It seems 
that probiotics can have an important role in the prevention of many diseases such 
as allergy. Microbiota diversity exists between allergic and nonallergic persons. 
Different mechanisms are considered for the anti-allergic impact of probiotics, like 
detecting related molecular patterns, including DNA motifs or LPS of the bacteria 
Figure 2. 
Good microbiome as a target for food allergy intervention.
Human Microbiome
8
Author details
Najaf Allahyari Fard1*, Zakie Mazhary2 and Nahid Javanshir1
1 National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
2 Islamic Azad University, Science and Research Branch, Tehran, Iran
*Address all correspondence to: allahyar@nigeb.ac.ir
by Toll-like receptors. Probiotic mechanism against the allergen includes increasing 
regulatory T cells that damp down immune responses and suppress the production 
of IgE.
Acknowledgements
The authors are thankful to the National Institute of Genetic Engineering and 
Biotechnology (NIGEB), Iran, for providing the facilities.
Conflict of interest
The authors declare no conflict of interest.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
9Probiotic Bacteria in Microbiome against Allergy
DOI: http://dx.doi.org/10.5772/intechopen.93385
References
[1] Zhang L et al. SORTALLER: 
Predicting allergens using substantially 
optimized algorithm on allergen family 
featured peptides. Bioinformatics. 
2012;28(16):2178-2179
[2] Goodman RE. Biosafety: Evaluation 
and regulation of genetically modified 
(GM) crops in the United States. Journal 
of Hauzhong Agricultural University. 
2014;33(6):85-114
[3] Goodman RE et al. Allergenicity 
assessment of genetically modified 
crops—What makes sense? Nature 
Biotechnology. 2008;26(1):73-81
[4] Hayes M et al. In silico tools for 
exploring potential human allergy to 
proteins. Drug Discovery Today: Disease 
Models. 2015;17:3-11
[5] Zoetendal EG, Akkermans AD, De 
Vos WM. Temperature gradient gel 
electrophoresis analysis of 16S rRNA 
from human fecal samples reveals stable 
and host-specific communities of active 
bacteria. Applied and Environmental 
Microbiology. 1998;64(10):3854-3859
[6] Neish AS. Microbes in 
gastrointestinal health and disease. 
Gastroenterology. 2009;136(1):65-80
[7] Morelli L. Postnatal development 
of intestinal microflora as influenced 
by infant nutrition. The Journal of 
Nutrition. 2008;138(9):1791S-1795S
[8] McCutcheon JP, Moran NA. Extreme 
genome reduction in symbiotic 
bacteria. Nature Reviews Microbiology. 
2012;10(1):13-26
[9] Stein MM et al. Innate immunity 
and asthma risk in Amish and Hutterite 
farm children. New England Journal of 
Medicine. 2016;375(5):411-421
[10] West CE et al. Probiotics for 
treatment and primary prevention of 
allergic diseases and asthma: Looking 
back and moving forward. Expert 
Review of Clinical Immunology. 
2016;12(6):625-639
[11] Zeiger RS. Food allergen avoidance 
in the prevention of food allergy 
in infants and children. Pediatrics. 
2003;111(Supplement 3):1662-1671
[12] West CE, Jenmalm M, Prescott S. 
The gut microbiota and its role in the 
development of allergic disease: A wider 
perspective. Clinical & Experimental 
Allergy. 2015;45(1):43-53
[13] Wesemann DR et al. Microbial 
colonization influences early B-lineage 
development in the gut lamina propria. 
Nature. 2013;501(7465):112-115
[14] Rodriguez B et al. Infant gut 
microbiota is protective against cow’s 
milk allergy in mice despite immature 
ileal T-cell response. FEMS Microbiology 
Ecology. 2012;79(1):192-202
[15] Wesemann DR, Nagler CR. The 
microbiome, timing, and barrier 
function in the context of allergic 
disease. Immunity. 2016;44(4):728-738
[16] Stefka AT et al. Commensal 
bacteria protect against food allergen 
sensitization. Proceedings of the 
National Academy of Sciences. 
2014;111(36):13145-13150
[17] Prescott SL, Björkstén B.  
Probiotics for the prevention or 
treatment of allergic diseases. Journal 
of Allergy and Clinical Immunology. 
2007;120(2):255-262
[18] Blázquez AB, Berin MC. Microbiome 
and food allergy. Translational 
Research. 2017;179:199-203
[19] Björkstén B. Effects of intestinal 
microflora and the environment on the 
development of asthma and allergy.  
Human Microbiome
10
In: Springer Seminars in 
Immunopathology. Springer; 2004
[20] Walker WA, Iyengar RS. Breast 
milk, microbiota, and intestinal 
immune homeostasis. Pediatric 
Research. 2015;77(1-2):220-228
[21] Nicholson JK et al. Host-gut 
microbiota metabolic interactions. 
Science. 2012;336(6086):1262-1267
[22] Kirjavainen PV, Gibson GR. 
Healthy gut microflora and allergy: 
Factors influencing development of 
the microbiota. Annals of Medicine. 
1999;31(4):288-292
[23] Nagler-Anderson C et al. Mucosal 
antigen presentation and the control 
of tolerance and immunity. Trends in 
Immunology. 2001;22(3):120-122
[24] Nagler-Anderson C. Man the 
barrier! Strategic defences in the 
intestinal mucosa. Nature Reviews 
Immunology. 2001;1(1):59-67
[25] Yu W, Freeland DMH, Nadeau KC. 
Food allergy: Immune mechanisms, 
diagnosis and immunotherapy. Nature 
Reviews Immunology. 2016;16(12):751
[26] Pabst O, Cerovic V, Hornef M. 
Secretory IgA in the coordination of 
establishment and maintenance of the 
microbiota. Trends in Immunology. 
2016;37(5):287-296
[27] Pabst O. New concepts in the 
generation and functions of IgA. 
Nature Reviews Immunology. 
2012;12(12):821-832
[28] Dzidic M et al. Aberrant IgA 
responses to the gut microbiota during 
infancy precede asthma and allergy 
development. Journal of Allergy and 
Clinical Immunology. 2017;139(3): 
1017-1025. e14
[29] Round JL, Mazmanian SK. Inducible 
Foxp3+ regulatory T-cell development 
by a commensal bacterium of the 
intestinal microbiota. Proceedings of 
the National Academy of Sciences. 
2010;107(27):12204-12209
[30] Bashir MEH et al. Toll-like receptor 
4 signaling by intestinal microbes 
influences susceptibility to food 
allergy. The Journal of Immunology. 
2004;172(11):6978-6987
[31] Rodríguez JM et al. The composition 
of the gut microbiota throughout life, 
with an emphasis on early life. Microbial 
Ecology in Health and Disease. 
2015;26(1):26050
[32] West CE et al. The gut microbiota 
and inflammatory noncommunicable 
diseases: Associations and potentials 
for gut microbiota therapies. Journal 
of Allergy and Clinical Immunology. 
2015;135(1):3-13
[33] Wang M et al. Reduced diversity 
in the early fecal microbiota of 
infants with atopic eczema. Journal 
of Allergy and Clinical Immunology. 
2008;121(1):129-134
[34] Ismail IH et al. Reduced gut 
microbial diversity in early life is 
associated with later development 
of eczema but not atopy in high-
risk infants. Pediatric Allergy and 
Immunology. 2012;23(7):674-681
[35] Bunyavanich S et al. Early-life 
gut microbiome composition and 
milk allergy resolution. Journal of 
Allergy and Clinical Immunology. 
2016;138(4):1122-1130
[36] Azad MB et al. Infant gut 
microbiota and food sensitization: 
Associations in the first year of life. 
Clinical & Experimental Allergy. 
2015;45(3):632-643
[37] Abrahamsson TR et al. Low 
diversity of the gut microbiota in 
infants with atopic eczema. Journal 
of Allergy and Clinical Immunology. 
2012;129(2):434-440. e2
11
Probiotic Bacteria in Microbiome against Allergy
DOI: http://dx.doi.org/10.5772/intechopen.93385
[38] Olszak T et al. Microbial exposure 
during early life has persistent effects on 
natural killer T cell function. Science. 
2012;336(6080):489-493
[39] Iweala OI, Nagler CR. Immune 
privilege in the gut: The establishment 
and maintenance of non-responsiveness 
to dietary antigens and commensal 
flora. Immunological Reviews. 
2006;213(1):82-100
[40] Iannitti T, Palmieri B. Therapeutical 
use of probiotic formulations in 
clinical practice. Clinical Nutrition. 
2010;29(6):701-725
[41] Hooper LV, Gordon JI. Commensal 
host-bacterial relationships in the gut. 
Science. 2001;292(5519):1115-1118
[42] Brandtzaeg P. Development of the 
mucosal immune system in humans. 
In: Recent developments in infant 
nutrition. Springer-Verlag GmbH 
Germany, part of Springer Nature; 1996. 
pp. 349-376
[43] Ouwehand AC et al. Prebiotics 
and other microbial substrates for 
gut functionality. Current Opinion in 
Biotechnology. 2005;16(2):212-217
[44] Adlerberth MC, Poilane I,  
Wold A, Collignon A, Ingegerd. 
Mechanisms of colonisation and 
colonisation resistance of the digestive 
tract part 1: Bacteria/host interactions. 
Microbial Ecology in Health and 
Disease. 2000;12(2):223-239
[45] Smith PM et al. The microbial 
metabolites, short-chain fatty acids, 
regulate colonic Treg cell homeostasis. 
Science. 2013;341(6145):569-573
[46] Furusawa Y et al. Commensal 
microbe-derived butyrate induces the 
differentiation of colonic regulatory T 
cells. Nature. 2013;504(7480):446-450
[47] Chang PV et al. The microbial 
metabolite butyrate regulates intestinal 
macrophage function via histone 
deacetylase inhibition. Proceedings 
of the National Academy of Sciences. 
2014;111(6):2247-2252
[48] Arpaia N, Rudensky AY. 
Microbial metabolites control gut 
inflammatory responses. Proceedings 
of the National Academy of Sciences. 
2014;111(6):2058-2059
[49] West CE et al. Gut microbiome 
and innate immune response 
patterns in Ig E-associated eczema. 
Clinical & Experimental Allergy. 
2015;45(9):1419-1429
[50] Sepp E et al. Intestinal microbiota 
and immunoglobulin E responses 
in 5-year-old estonian children. 
Clinical & Experimental Allergy. 
2005;35(9):1141-1146
[51] Kalliomäki M et al. Distinct 
patterns of neonatal gut microflora 
in infants in whom atopy was and 
was not developing. Journal of 
Allergy and Clinical Immunology. 
2001;107(1):129-134
[52] Ouwehand AC et al. Differences 
in Bifidobacterium flora composition 
in allergic and healthy infants. Journal 
of Allergy and Clinical Immunology. 
2001;108(1):144-145
[53] Murray C et al. Fecal microbiota in 
sensitized wheezy and non-sensitized 
non-wheezy children: A nested case–
control study. Clinical & Experimental 
Allergy. 2005;35(6):741-745
[54] He F et al. Intestinal Bifidobacterium 
species induce varying cytokine 
production. Journal of Allergy 
and Clinical Immunology. 
2002;109(6):1035-1036
[55] Morita H et al. Adhesion of lactic 
acid bacteria to Caco-2 cells and 
their effect on cytokine secretion. 
Microbiology and Immunology. 
2002;46(4):293-297
Human Microbiome
12
[56] He F et al. Comparison of mucosal 
adhesion and species identification of 
bifidobacteria isolated from healthy 
and allergic infants. FEMS Immunology 
and Medical Microbiology. 
2001;30(1):43-47
[57] Norin E, Midtvedt T, Björkstén B. 
Development of faecal short-chain 
fatty acid pattern during the first year 
of life in Estonian and Swedish infants. 
Microbial Ecology in Health and 
Disease. 2004;16(1):8-12
[58] Brandtzaeg P. Current 
understanding of gastrointestinal 
immunoregulation and its relation 
to food allergy. Annals of the 
New York Academy of Sciences. 
2002;964(1):13-45
[59] Saavedra J, Tschernia A. Human 
studies with probiotics and prebiotics: 
Clinical implications. British Journal of 
Nutrition. 2002;87(S2):S241-S246
[60] Salinas I et al. Monospecies and 
multispecies probiotic formulations 
produce different systemic and local 
immunostimulatory effects in the 
gilthead seabream (Sparus aurata L.).  
Fish & Shellfish Immunology. 
2008;25(1-2):114-123
[61] Wickens K et al. A differential 
effect of 2 probiotics in the prevention 
of eczema and atopy: A double-blind, 
randomized, placebo-controlled 
trial. Journal of Allergy and Clinical 
Immunology. 2008;122(4):788-794
[62] West CE, Hammarström ML, 
Hernell O. Probiotics in primary 
prevention of allergic disease–
follow-up at 8-9 years of age. Allergy. 
2013;68(8):1015-1020
[63] West CE et al. Effects of feeding 
probiotics during weaning on 
infections and antibody responses to 
diphtheria, tetanus and Hib vaccines. 
Pediatric Allergy and Immunology. 
2008;19(1):53-60
[64] Rutten N et al. Long term 
development of gut microbiota 
composition in atopic children: 
impact of probiotics. PLoS One. 
2015;10(9):e0137681
[65] Dotterud CK et al. Does maternal 
perinatal probiotic supplementation 
alter the intestinal microbiota of 
mother and child? Journal of Pediatric 
Gastroenterology and Nutrition. 
2015;61(2):200-207
[66] Atarashi K et al. Induction 
of colonic regulatory T cells by 
indigenous Clostridium species. Science. 
2011;331(6015):337-341
[67] Atarashi K et al. T reg induction by a 
rationally selected mixture of Clostridia 
strains from the human microbiota. 
Nature. 2013;500(7461):232-236
[68] Round JL, Mazmanian SK. The 
gut microbiota shapes intestinal 
immune responses during health and 
disease. Nature Reviews Immunology. 
2009;9(5):313-323
[69] Sabat R, Ouyang W, Wolk K. 
Therapeutic opportunities of the IL- 
22–IL-22R1 system. Nature Reviews 
Drug Discovery. 2014;13(1):21-38
[70] Strachan DP. Family size, 
infection and atopy: The first decade 
of the’hygiene hypothesis’. Thorax. 
2000;55(Suppl 1):S2
[71] Noverr MC, Huffnagle GB. The 
‘microflora hypothesis’ of allergic 
diseases. Clinical & Experimental. 
Allergy. 2005;35(12):1511-1520
[72] Tang R-B. Risk factors associated 
with the development of asthma. 
Journal of the Chinese Medical 
Association. 2005;68(5):199-201
[73] Winkler P et al. Molecular and 
cellular basis of microflora-host 
interactions. Journal of Nutrition. 
2007;137(3):756S-772S
13
Probiotic Bacteria in Microbiome against Allergy
DOI: http://dx.doi.org/10.5772/intechopen.93385
[74] Simon AK, Hollander GA, 
McMichael A. Evolution of the immune 
system in humans from infancy to 
old age. Proceedings of the Royal 
Society B: Biological Sciences. 
2015;282(1821):20143085
[75] Ouwehand AC. Antiallergic effects 
of probiotics. Journal of Nutrition. 
2007;137(3):794S-797S
[76] Tang R-B, Chang J-K, Chen H-L. 
Can probiotics be used to treat allergic 
diseases? Journal of the Chinese Medical 
Association. 2015;78(3):154-157
[77] Paibomesai MA. Epigenetic 
influences on bovine T-helper 1 and 
T-helper 2 cytokines (interferon-
gamma and Interleukin-4) in high and 
low immune responders around the 
peripartum period [Diss.]; 2017
[78] Daley D. The evolution of the 
hygiene hypothesis: The role of early-
life exposures to viruses and microbes 
and their relationship to asthma and 
allergic diseases. Current Opinion in 
Allergy and Clinical Immunology. 
2014;14(5):390-396
[79] Deo SS et al. Role played by Th2 
type cytokines in IgE mediated allergy 
and asthma. Lung India: Official Organ 
of Indian Chest Society. 2010;27(2):66
[80] Ngoc LP et al. Cytokines, allergy, 
and asthma. Current Opinion in 
Allergy and Clinical Immunology. 
2005;5(2):161-166
[81] Jae LB, Bak Y-T. Irritable bowel 
syndrome, gut microbiota and 
probiotics. Neurogastroenterology & 
Motility. 2011;17(3):252
[82] Rabia A, Shah NP. Immune 
system stimulation by probiotic 
microorganisms. Critical Reviews 
in Food Science and Nutrition. 
2014;54(7):938-956
[83] Stephanie W et al. Effects of 
probiotics on atopic dermatitis: 
A randomised controlled trial. 
Archives of Disease in Childhood. 
2005;90(9):892-897
[84] Perceval C et al. Prophylactic 
use of probiotics for gastrointestinal 
disorders in children. The Lancet 
Child & Adolescent Health. 
2019;3(9):655-662
[85] Sofia R et al. Gut microbiota profile 
in children affected by atopic dermatitis 
and evaluation of intestinal persistence 
of a probiotic mixture. Scientific 
Reports. 2019;9(1)
[86] Fang Z et al. Strain-specific 
ameliorating effect of Bifidobacterium 
longum on atopic dermatitis in 
mice. Journal of Functional Foods. 
2019;60:103426
[87] Hamdan AL-J et al. Asthma 
control and predictive factors among 
adults in Saudi Arabia: Results from 
the epidemiological study on the 
Management of Asthma in asthmatic 
Middle East adult population study. 
Annals of Thoracic Medicine. 
2019;14(2):148
[88] Ahanchian H et al. Probiotics 
for the treatment of asthma: A 
systematic review and meta-analysis of 
randomized trials. International Journal 
of Pediatrics. 2020;8(5):11271-11285
[89] Johnson C. Asthma flare-ups in 
children returning to school: New blood 
screening device developed: More bowel 
cancer cases for under 50s. Australian 
Medicine. 2019;31(2):25
[90] Wei X et al. Association between 
probiotic supplementation and asthma 
incidence in infants: A meta-analysis 
of randomized controlled trials. The 
Journal of Asthma. 2020;57(2):167-178
[91] Wu C-T et al. Effect of Lactobacillus 
rhamnosus GG immunopathologic 
changes in chronic mouse asthma 
model. Journal of Microbiology, 
Human Microbiome
14
Immunology and Infection. 
2019;52(6):911-919
[92] Schaefer M, Enck P. Effects of 
a probiotic treatment (Enterococcus 
faecalis) and open-label placebo on 
symptoms of allergic rhinitis: Study 
protocol for a randomised controlled 
trial. BMJ Open. 2019;9:e031339.  
DOI: 10.1136/bmjopen-2019-031339
[93] Dehnavi S et al. A significant 
decrease in the gene expression 
of interleukin-17 following the 
administration of synbiotic in patients 
with allergic rhinitis who underwent 
immunotherapy: A placebo-controlled 
clinical trial. Journal of Research in 
Medical Sciences: The Official Journal of 
Isfahan University of Medical Sciences. 
2019;24:1-7
[94] Sadeghi-Shabestari M et al. Effect 
of probiotics on allergic rhinitis: A 
randomized, controlled, clinical trial. 
Galen Medical Journal. 2020;9:1918
[95] Giovannini M, Agostoni C, Riva E, 
Salvini F, Ruscitto A, Zuccotti GV, et 
al. A randomized prospective double 
blind controlled trial on effects of 
long-term consumption of fermented 
milk containing Lactobacillus caseiin 
pre-school children with allergic asthma 
and/or rhinitis. Pediatric Research. 
2007;62:215-220
[96] Helin T, Haahtela S, Haahtela T. 
No effect of oral treatment with an 
intestinal bacterial strain, Lactobacillus 
rhamnosus (ATCC 53103), on birch-
pollen allergy: A placebo-controlled 
double-blind study. Allergy. 
2002;57:243-246
[97] Yang G, Liu ZG, Yang PC. 
Treatment of allergic rhinitis with 
probiotics; an alternative approach. 
North American Journal of Medical 
Sciences. 2013;5:465-468
[98] Das RR, Singh M, Shafiq N. 
Probiotics in treatment of allergic 
rhinitis. World Allergy Organization 
Journal. 2010;3:239-244
[99] Marcello G et al. A randomized 
prospective double blind controlled trial 
on effects of long-term consumption of 
fermented milk containing Lactobacillus 
casei in pre-school children with allergic 
asthma and/or rhinitis. Pediatric 
Research. 2007;62(2):215-220
[100] Miguel S, Lu P, Bonilla S. Cow’s-
milk allergy is a risk factor for the 
development of FGIDs in children. 
Journal of Pediatric Gastroenterology 
and Nutrition. 2011;52(2):166-169
[101] Virta LJ, Kautiainen H, Kolho 
K-L. Symptoms suggestive of cow’s 
milk allergy in infancy and pediatric 
inflammatory bowel disease. 
Pediatric Allergy and Immunology. 
2016;27(4):361-367
[102] Filippis D, Francesca, et al. High-
level adherence to a Mediterranean diet 
beneficially impacts the gut microbiota 
and associated metabolome. Gut. 
2016;65(11):1812-1821
[103] Roberto BC et al. Gut microbiome 
as target for innovative strategies against 
food allergy. Frontiers in Immunology. 
2019;10:191
[104] Castro-Rodriguez JA, 
Garcia-Marcos L. What are the effects 
of a Mediterranean diet on allergies 
and asthma in children? Frontiers in 
Pediatrics. 2017;5:72
[105] Craig MK et al. The nutrition-gut 
microbiome-physiology axis and allergic 
diseases. Immunological Reviews. 
2017;278(1):277-295
[106] Louis P, Flint HJ. Diversity, 
metabolism and microbial ecology 
of butyrate-producing bacteria from 
the human large intestine. FEMS 
Microbiology Letters. 2009;294(1):1-8
[107] Schauber J et al. Expression of 
the cathelicidin LL-37 is modulated by 
15
Probiotic Bacteria in Microbiome against Allergy
DOI: http://dx.doi.org/10.5772/intechopen.93385
short chain fatty acids in colonocytes: 
Relevance of signalling pathways. Gut. 
2003;52(5):735-741
[108] Luying P et al. Butyrate enhances 
the intestinal barrier by facilitating 
tight junction assembly via activation of 
AMP-activated protein kinase in Caco-2 
cell monolayers. Journal of Nutrition. 
2009;139(9):1619-1625
[109] Brown AJ et al. The orphan G 
protein-coupled receptors GPR41 and 
GPR43 are activated by propionate 
and other short chain carboxylic acids. 
The Journal of Biological Chemistry. 
2003;278(13):11312-11319
[110] Nilsson NE et al. Identification 
of a free fatty acid receptor, 
FFA2R, expressed on leukocytes 
and activated by short-chain fatty 
acids. Biochemical and Biophysical 
Research Communications. 
2003;303(4):1047-1052
